A spotlight for our experiences with DCTs from an emerging biotech point of view. ASC Therapeutics is leveraging home-based HCPs as a patient-centric way to incorporate DCT methodologies into a study investigating gene therapy for second-generation hemophilia A
In this week's issue, we'll explore what our editors Dan Schell and Abby Proch learned at the 2024 SCOPE Summit, the pros and cons of basing trials in Europe, AI's impact on drug discovery and development, trends and predictions for safety and regulatory compliance, and other popular insights. #clinicalresearch #clinicaltrials #linkedinnewsletter